Genetic alterations associated with ALTered telomeres
Genetic alterations associated with ALTered telomeres |
https://doi.org/10.18632/oncotarget.26111
Jacqueline A. Brosnan-Cashman,
Mindy K. Graham,
and Christopher M. Heaphy
|
33739-33740 |
Systemic therapy for hepatocellular carcinoma: trial enrichment does not guarantee success
Systemic therapy for hepatocellular carcinoma: trial enrichment does not guarantee success |
https://doi.org/10.18632/oncotarget.26052
Leonardo G. Da Fonseca,
Maria Reig,
and Jordi Bruix
|
33741-33742 |
Genomic mechanisms of immune evasion in colorectal cancer: from discovery to clinical practice
Genomic mechanisms of immune evasion in colorectal cancer: from discovery to clinical practice |
https://doi.org/10.18632/oncotarget.26105
Catherine S. Grasso,
and Marios Giannakis
|
33743-33744 |
Nuclear PKM2 promotes the progression of oral squamous cell carcinoma by inducing EMT and post-translationally repressing TGIF2
Nuclear PKM2 promotes the progression of oral squamous cell carcinoma by inducing EMT and post-translationally repressing TGIF2 |
https://doi.org/10.18632/oncotarget.25850
Fumie Tanaka,
Shohei Yoshimoto,
Kazuhiko Okamura,
Tetsuro Ikebe,
and Shuichi Hashimoto
|
33745-33761 |
Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer
Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer |
https://doi.org/10.18632/oncotarget.26031
Mathilde Guerin,
Anthony Gonçalves,
Yves Toiron,
Emilie Baudelet,
Matthieu Pophillat,
Samuel Granjeaud,
Patrick Fourquet,
William Jacot,
Carole Tarpin,
Renaud Sabatier,
Emilie Agavnian,
Pascal Finetti,
José Adelaide,
Daniel Birnbaum,
Christophe Ginestier,
Emmanuelle Charafe-Jauffret,
Patrice Viens,
François Bertucci,
Jean-Paul Borg,
and Luc Camoin
|
33762-33777 |
The close relationship between heparanase and epithelial mesenchymal transition in gastric signet-ring cell adenocarcinoma
The close relationship between heparanase and epithelial mesenchymal transition in gastric signet-ring cell adenocarcinoma |
https://doi.org/10.18632/oncotarget.26042
Shahid Shah,
Caroline Fourgeaud,
Simon Derieux,
Shahsoltan Mirshahi,
Geneviève Contant,
Cynthia Pimpie,
Rea Lo Dico,
Jeannette Soria,
Marc Pocard,
and Massoud Mirshahi
|
33778-33787 |
RND1 regulates migration of human glioblastoma stem-like cells according to their anatomical localization and defines a prognostic signature in glioblastoma
RND1 regulates migration of human glioblastoma stem-like cells according to their anatomical localization and defines a prognostic signature in glioblastoma |
https://doi.org/10.18632/oncotarget.26082
Sabrina Boyrie,
Caroline Delmas,
Anthony Lemarié,
Vincent Lubrano,
Perrine Dahan,
Laure Malric,
José Luis,
Julia Gilhodes,
Marie Tosolini,
Laetitia Mouly,
Maxime Lehmann,
Christine Toulas,
Elizabeth Cohen-Jonathan Moyal,
and Sylvie Monferran
|
33788-33803 |
Can computer-aided diagnosis assist in the identification of prostate cancer on prostate MRI? a multi-center, multi-reader investigation
Can computer-aided diagnosis assist in the identification of prostate cancer on prostate MRI? a multi-center, multi-reader investigation |
https://doi.org/10.18632/oncotarget.26100
Sonia Gaur,
Nathan Lay,
Stephanie A. Harmon,
Sreya Doddakashi,
Sherif Mehralivand,
Burak Argun,
Tristan Barrett,
Sandra Bednarova,
Rossanno Girometti,
Ercan Karaarslan,
Ali Riza Kural,
Aytekin Oto,
Andrei S. Purysko,
Tatjana Antic,
Cristina Magi-Galluzzi,
Yesim Saglican,
Stefano Sioletic,
Anne Y. Warren,
Leonardo Bittencourt,
Jurgen J. Fütterer,
Rajan T. Gupta,
Ismail Kabakus,
Yan Mee Law,
Daniel J. Margolis,
Haytham Shebel,
Antonio C. Westphalen,
Bradford J. Wood,
Peter A. Pinto,
Joanna H. Shih,
Peter L. Choyke,
Ronald M. Summers,
and Baris Turkbey
|
33804-33817 |
Mitochondria as oncotarget: a comparison between the tetracycline analogs doxycycline and COL-3
Mitochondria as oncotarget: a comparison between the tetracycline analogs doxycycline and COL-3 |
https://doi.org/10.18632/oncotarget.26107
Margherita Protasoni,
Albert M. Kroon,
and Jan-Willem Taanman
|
33818-33831 |
Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells
Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells |
https://doi.org/10.18632/oncotarget.26112
Shogo Okazaki,
Subaru Shintani,
Yuki Hirata,
Kentaro Suina,
Takashi Semba,
Juntaro Yamasaki,
Kiyoko Umene,
Miyuki Ishikawa,
Hideyuki Saya,
and Osamu Nagano
|
33832-33843 |
The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse model
The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse model |
https://doi.org/10.18632/oncotarget.26117
Tatsuzo Mizukami,
Hirofumi Kamachi,
Yuki Fujii,
Fumihiko Matsuzawa,
Takahiro Einama,
Futoshi Kawamata,
Nozomi Kobayashi,
Yutaka Hatanaka,
and Akinobu Taketomi
|
33844-33852 |
Toxicity of JQ1 in neuronal derivatives of human umbilical cord mesenchymal stem cells
Toxicity of JQ1 in neuronal derivatives of human umbilical cord mesenchymal stem cells |
https://doi.org/10.18632/oncotarget.26127
Shreeya Bakshi,
Christina McKee,
Keegan Walker,
Christina Brown,
and G. Rasul Chaudhry
|
33853-33864 |
Correction: The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth
Correction: The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth |
https://doi.org/10.18632/oncotarget.26156
Harini Nivarthi,
Claire Gordziel,
Madeleine Themanns,
Nina Kramer,
Markus Eberl,
Björn Rabe,
Michaela Schlederer,
Stefan Rose-John,
Thomas Knösel,
Lukas Kenner,
Patricia Freund,
Fritz Aberger,
Xiaonan Han,
Robert Kralovics,
Helmut Dolznig,
Susanne Jennek,
Karlheinz Friedrich,
and Richard Moriggl
|
33865-33865 |
Erratum: Drug-Targeted Inhibition of Peroxisome Proliferator-Activated Receptor-gamma Enhances the Chemopreventive Effect of Anti-Estrogen Therapy
Erratum: Drug-Targeted Inhibition of Peroxisome Proliferator-Activated Receptor-gamma Enhances the Chemopreventive Effect of Anti-Estrogen Therapy |
https://doi.org/10.18632/oncotarget.26161
Hongyan Yuan,
Levy Kopelovich,
Yuzhi Yin,
Jin Lu,
and Robert I. Glazer
|
33866-33866 |